格隆汇12月5日丨联泓新科(003022.SZ)公布，为积极响应国家科技创新政策导向，落实公司创新驱动发 展战略，加大科技创新投入力度，同时进一步拓宽融资渠道，降低融资成本，优化债务结构，联泓新材 料科技股份有限公司拟向中国银行间市场交易商协会申请注册发行最高不超过人民币10亿元（含10亿 元）科技创新债券。 ...

三、公司应按照《非金融企业债务融资工具发行规范指引》和《非金融企业债务融资工具簿记建档发行 工作规程》开展发行工作。 公司将严格按照有关法律法规、交易商协会相关自律管理规定及上述《接受注册通知书》的要求，充分 考虑公司资金需求和市场情况，在注册有效期内择机发行科技创新债券，并按照有关规定及时履行信息 披露义务。 特此公告。 奇安信科技集团股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 奇安信科技集团股份有限公司（以下简称"公司"）于2025年9月12日和2025年9月29日分别召开第三届董 事会第四次会议和2025年第二次临时股东大会，审议通过了《关于拟申请注册发行银行间债券市场非金 融企业债务融资工具的议案》，同意公司向中国银行间市场交易商协会（以下简称"交易商协会"）申请 注册发行总额不超过人民币20亿元的科技创新债券。其中，中期票据不超过人民币10亿元，超短期融资 券不超过人民币10亿元。具体内容详见公司分别于2025年9月13日和2025年9月30日在 ...

本期债券由中国国际金融股份有限公司担任牵头主承销商，招商证券股份有限公司与中信建投 （601066）证券股份有限公司担任联席主承销商。 本期债券分两个品种发行。品种一(债券简称：25招商银行科创债01，代码：2528029)为3年期浮动利率 债券，实际发行总额35亿元，首期票面利率为1.82%，利率每3个月根据基准利率重定价调整。品种二 (代码：2528030)为5年期固定利率债券，实际发行总额15亿元，票面利率为1.82%。 经济观察网中国货币网12月4日消息，招商银行（600036）股份有限公司于2025年12月3日成功发 行"2025年招商银行股份有限公司第一期科技创新债券(债券通)"，本期债券发行总额合计50亿元，为首 批面向科技创新领域并通过债券通机制发行的专项金融债券之一。 ...

1. Report Industry Investment Rating No relevant information provided. 2. Core Viewpoints of the Report - In the short - term, supply - demand and prices are the two major economic concerns. The manufacturing industry was in a state of passive de - stocking in November, and the relationship between production and demand improved slightly. However, the sustainability needs to be observed, and the endogenous demand in consumption and real estate needs to be strengthened. The price index has been repaired, with the front - end stronger than the back - end in structure [28]. - After the December Politburo meeting, the general policy direction for 2026 will be set, and the subsequent Central Economic Work Conference will make further deployments. Key areas of focus include monetary policy, fiscal policy, technological self - reliance, etc. The overall environment is favorable for the market [28]. 3. Summary of Each Section 3.1 Macro Data Overview - GDP growth rate in Q3 2025 was 4.8% year - on - year, down from 5.2% in the previous quarter but up from 4.6% in the same period last year [1]. - In November 2025, the manufacturing PMI was 49.2%, slightly up from 49.0% in the previous month but down from 50.3% in the same period last year; the non - manufacturing PMI for business activities was 49.5%, down from 50.1% in the previous month and 50.0% in the same period last year [1]. - In October 2025, the monthly increase in social financing scale was 816.1 billion yuan, significantly lower than 3529.9 billion yuan in the previous month but higher than 1412.0 billion yuan in the same period last year [1]. 3.2 Commodity Investment Reference 3.2.1 Comprehensive - From December 3, 2025, the speculative trading margin standard for the polysilicon futures PS2601 contract will be adjusted to 13%, and the hedging trading margin standard to 12%. The daily opening volume limit for non - futures company members or clients will be 500 lots [2]. - China's S&P manufacturing PMI in November was 49.9, down from 50.6 in the previous month [3]. - On December 1, 36 domestic commodity varieties had positive basis, and 30 had negative basis [3]. - The Bank of Japan Governor signaled a possible interest rate hike [3]. 3.2.2 Metals - Due to supply shortages and expectations of Fed rate cuts, silver prices soared to record highs. On Monday, spot silver reached over $58 per ounce, with a year - to - date increase of over 100% [4]. - On December 1, the price of battery - grade lithium carbonate rose to 94,400 yuan/ton, and the price of lithium hydroxide rose to 82,500 yuan/ton [5]. - As of November 28, lead, aluminum, and nickel inventories decreased, while zinc inventory increased [6]. 3.2.3 Coal, Coking, Steel, and Minerals - The China Iron and Steel Association emphasized accelerating key iron ore projects to enhance the industry's resource security capacity [8]. - Saudi Arabia launched a new round of mineral exploration tenders covering 13,000 square kilometers [8]. - Indonesia set the benchmark prices for different grades of coal for the first half of December [8]. 3.2.4 Energy and Chemicals - Two shale gas industry standards will be implemented on March 28, 2026, to support shale gas development [10]. - On December 1, international oil prices rose due to geopolitical risks and supply - side factors [10]. - Saudi Aramco and Algerian National Oil Company raised LPG prices by 3% - 5% in December [10]. 3.2.5 Agricultural Products - The domestic corn market has been rising strongly, with significant price increases in major ports [11]. - On December 1, the domestic live - hog futures contract 2601 was at a low level, and the spot market prices mostly fell [11]. - The USDA reported weekly export sales data for various agricultural products in the US [11][12]. 3.3 Financial News Compilation 3.3.1 Open Market - On December 1, the central bank conducted 107.6 billion yuan of 7 - day reverse repurchase operations, with a net withdrawal of 231.1 billion yuan [14]. 3.3.2 Key News - French President Macron will visit China from December 3 - 5 [15]. - The CSRC is promoting the pilot of commercial real estate investment trusts (REITs) to support the real estate market [16]. - As of the end of October, the balance of loans in the Yangtze River Delta region showed certain growth trends [17]. - In November, new energy vehicle sales rankings were released, with BYD leading [17]. 3.3.3 Bond Market Summary - The Chinese bond market was mostly strong and volatile. Interest - rate bond yields mostly declined, and treasury - bond futures had mixed performance [21]. - Exchange - traded bonds, especially Vanke bonds, generally declined [21]. - The CSI Convertible Bond Index rose 0.10% [22]. 3.3.4 Foreign Exchange Market - The on - shore RMB against the US dollar rose 69 basis points on December 1 [27]. - The US dollar index fell 0.03% in New York trading [27]. 3.3.5 Research Report Highlights - Huatai Fixed - Income commented on the November official manufacturing PMI, highlighting supply - demand and price concerns [28]. - Guosheng Macro's Xiong Yuan released a report on the possible policy directions after the December Politburo meeting [28]. 3.3.6 Today's Reminders - On December 2, 155 bonds will be listed, 101 bonds will be issued, 54 bonds will be settled, and 135 bonds will pay principal and interest [29][30]. 3.4 Stock Market Key News - A - shares rose unilaterally, with technology themes active. The Shanghai Composite Index rose 0.65%, and the trading volume expanded to 1.89 trillion yuan [31]. - The Hong Kong Hang Seng Index rose 0.67%, and the Southbound funds had a net purchase of HK$2.148 billion [31]. - Shenzhen Stock Exchange will adjust samples of multiple indices on December 15 [31].

新华财经北京12月1日电 1日获悉，北京盛景嘉成投资管理有限公司（简称"盛景嘉成"）当日在银行间 债券市场发行"北京盛景嘉成投资管理有限公司2025年度第一期定向科技创新债券（分担工具） "（简 称"25盛景嘉成PPN001（科创债）"），系第二批获得中国人民银行科技创新债券风险分担工具支持的 民营股权投资机构发行的科创债，也是北京市唯一参与第二批发行民营股权投资机构科创债的机构。 本期债券注册总规模4亿元，首期发行2亿元，期限为"5+5"年，由国信证券担任牵头主承销商，邮政储 蓄银行、交通银行、招商银行、浦发银行、渤海银行、北京银行、杭州银行等多家金融机构共同参与承 销。本期债券创新引入风险分担机制，由中债信用增进投资股份有限公司提供全额担保，主体信用评级 AA级、债券信用评级达到AAA级，有效增强了市场认可度。 盛景嘉成是我国本土具有代表性的民营股权投资机构，自2011年成立以来始终聚焦科技创新领域投资。 公司依托母基金与直投基金"双轮驱动"，深耕人工智能、半导体、新材料、医疗健康等战略性新兴产 业，坚持"投早、投小、投硬科技"的投资策略。截至今年10月，公司管理规模超过130亿元，投资组合 中已有260 ...

Group 1 - The event "Rongyi Shang" organized by Chengdu aims to enhance the understanding of listing policies and bond issuance among local enterprises, with participation from over 20 quality representative companies from Chengdu [3][5] - Experts from the Shenzhen Stock Exchange provided insights on the latest policies regarding enterprise listings, IPO inspections, and the latest regulations on technology innovation bonds, ABS, and REITs [5][6] - The event included a visit to BYD headquarters, where attendees learned about BYD's advancements in the electronic, automotive, new energy, and rail transportation sectors, with a projected 4.27 million sales of new energy vehicles in 2024 [8][10] Group 2 - Chengdu has implemented a comprehensive service plan for enterprises throughout their listing lifecycle, focusing on building strong industrial chains and promoting high-quality development of listed companies [10] - The number of listed companies in Chengdu has been steadily increasing, with a total of 153 companies currently listed and 34 new additions in the past three years; there are over 700 companies in the pipeline for listing [10] - In the first three quarters of 2025, Chengdu's enterprises achieved direct financing of 263.34 billion yuan, indicating a significant increase in capital market activity [10]

Core Points - The company has issued its first phase of technology innovation bonds for 2025, with a total issuance amount of 50 million RMB [2] - The bonds have a maturity of 365 days and an interest rate of 3.19% [2] - The funds raised will be used to optimize the company's debt structure, broaden financing channels, and reduce financial costs, while also supporting national technology innovation policies [2] Summary by Sections - **Bond Issuance Details** - The company has completed the issuance of the 2025 first phase technology innovation bonds, with an issuance amount of 50 million RMB [2] - The bonds have a face value of 100 RMB and are organized by Shanghai Rural Commercial Bank as the lead underwriter [2] - **Purpose of Fundraising** - The raised funds will be utilized to optimize the company's debt structure and expand financing channels [2] - The company aims to lower financial costs and increase investment in technology innovation in response to national policies [2]

Group 1 - Zhejiang Longsheng Group Co., Ltd. has received approval to issue short-term financing bonds with a registered amount of up to RMB 3 billion [1][2] - The registration is valid for two years from the date of the acceptance notice issued by the trading association [2] - The company plans to issue the bonds in phases according to its funding needs and market conditions [2] Group 2 - The company has signed a partnership agreement to invest in the Shanghai Xianghui No. 1 Venture Capital Partnership, committing RMB 200 million, which accounts for 26.93% of the total capital raised of RMB 742.7 million [5][9][21] - This investment does not constitute a related party transaction or a major asset restructuring [6][10] - The partnership aims to invest in emerging industries with competitive advantages and good growth prospects, focusing on projects related to Fudan University's ecosystem [14][19] Group 3 - The partnership will have a management fee of 2% per year during the investment period, and 1.9% per year during the exit period [25] - The investment exit strategies include selling shares after an IPO, transferring equity, or receiving distributions upon liquidation [19][27] - The partnership's operational period is set for 9 years from the first closing date [29]

Core Viewpoint - The article highlights the emergence of private equity investment institutions utilizing technology innovation bonds, supported by risk-sharing tools, to enhance financing opportunities in the bond market [1][2]. Group 1: Technology Innovation Bonds - Four private equity investment institutions are set to issue a total of 930 million yuan in technology innovation bonds, marking the second batch to receive support from the "Technology Innovation Bond Risk Sharing Tool" [1]. - Base Capital plans to issue 400 million yuan in technology innovation bonds with a 10-year term and an AAA rating, benefiting from a guarantee provided by Zhongdai Credit Enhancement Investment Co., Ltd. [1][2]. - The "Technology Innovation Bond Risk Sharing Tool" was introduced to facilitate the issuance of these bonds, with the People's Bank of China providing low-cost re-lending funds [1]. Group 2: Impact on Private Equity Investment Institutions - The risk-sharing tool allows private equity investment institutions to use equity in their invested companies as collateral, a significant shift from traditional asset-based guarantees [2]. - The tool has opened new financing pathways for private equity firms, addressing challenges in fundraising and aligning bond terms with the long development cycles of hard technology enterprises [2][3]. - The first batch of the risk-sharing tool has already helped five private equity institutions raise 1.35 billion yuan in technology innovation bonds, with nearly 50% of the funds already deployed in various sectors [2]. Group 3: Market Trends and Future Outlook - As of November 21, 55 private enterprises have issued a total of 107.4 billion yuan in technology innovation bonds, indicating a growing trend in the market [3]. - The China Interbank Market Dealers Association aims to enhance the efficiency of bond registration and issuance processes to further support financial backing for technological innovation [3].

Core Viewpoint - The issuance of the technology innovation bonds by Jiuan Medical was successful, achieving an AAA credit rating and a 1.83% issuance interest rate, with an initial issuance scale of 1.05 billion yuan, reflecting market trust and recognition of the company's development [1]. Group 1: Company Overview - Jiuan Medical is primarily known for producing common household health monitoring devices such as thermometers, blood pressure monitors, and pulse oximeters, but it has diversified into home medical health products, internet healthcare, and technology investment [1]. - The company plans to invest approximately 270 million yuan in research and development in 2024, focusing on projects like continuous glucose monitoring (CGM) and AIoT diabetes home assistance [1]. Group 2: Bond Issuance Process - The company faced initial challenges in the bond issuance process, particularly regarding credit rating, but successfully communicated with rating agencies to demonstrate asset quality and financial health, ultimately achieving an AAA rating [2][3]. - The technology innovation bonds are designed to meet the financing needs of technology companies, allowing funds to be used for R&D, direct investments, and fund contributions, thereby enhancing capital turnover efficiency and reducing overall financing costs [2]. Group 3: Market Context and Challenges - Jiuan Medical's financial indicators met the requirements for issuing technology innovation bonds, and its intellectual property, including FDA approval, was considered a significant asset in the evaluation process [3]. - The company expressed concerns about the bond market's unfamiliarity, including questions about the efficiency of the issuance process and the potential for successful fundraising, which were addressed in a policy briefing organized by the China Interbank Market Dealers Association [3]. Group 4: Industry Implications - The issuance of technology innovation bonds is expected to inject new momentum into Jiuan Medical and its associated funds, accelerating the transformation of quality projects and technological achievements [4]. - The current challenge for many technology innovation companies is their asset-light operating model, which often lacks public market ratings, limiting support from traditional financing channels [4][5].